Results with Lifescozul

Raúl Manzano Murillo - Thyroid Cancer- Resultados con LifEscozul™ Thyroid Cancer

Introduction to the case

Thyroid cancer, as its name suggests, occurs in the thyroid gland, which has the function of forming thyroid hormones that help the body use energy, maintain body temperature and regulate the functioning of organs such as the brain, heart, muscles, among others.

It is a relatively rare type of cancer, compared to other cancers where less than 2,000 patients die of thyroid cancer each year, as it usually responds very well to conventional treatment and can often be cured with surgery and iodine.

It tends to grow slowly and often spreads to the lymph nodes in the neck. However, unlike other cancers, papillary cancer has an excellent prognosis, even when it has spread to the lymph nodes.

And despite this positive statistic, none of the treatments to treat his thyroid cancer worked for Raul Manzano and he decided to enter the LifEscozul Protocol (escozul, blue scorpion venom).

  • Clinical Data

    Raúl Manzano Murillo, 59 Años de edad al inicio del tratamiento con LifEscozul.

  • Symptomatology

    Throbbing pain in the neck, swelling of the face, phlegm, insomnia, depression.

  • Protocol Start

    July 2018.

  • Diagnostics

    Papillary thyroid carcinoma operated, with local and cervical lymph node infiltration (bilateral radical thyroidectomy).

    He received radiation after surgery.

    He presented recurrence in October 2017 with bilateral metastatic lesions in the neck.


Raul was detected with thyroid cancer in 2016 and underwent surgery in April 2016 for papillary thyroid carcinoma.

At the end of 2017 he was detected new tumor nodules on both sides of his neck, with no possibility of operation due to fibrosis after surgery and iodotherapies received, he was not offered treatment option.

When he came to the LifEscozul Protocol (blue scorpion venom, escozul) in June 2018 he was looking for a treatment alternative that would help him fight the disease in an effective way.

The LifEscozul Medical Group carefully reviewed the information and proceeded to accept the case. Raul was informed of the corresponding dosage, how the dose increases would be and the need to maintain close contact with the assigned physician.

Evolution with LifEscozul and actual results

Prior to the agreement, Raul has been personally in communication with the Doctor assigned to his case since the beginning of the treatment through periodic reports and sending medical documentation.

The first results he begins to notice in mid-August 2018, when he comments that he has felt that the swelling in his face was beginning to subside and that he had been feeling very well.

In November 2018 Raul refers that he continues to feel well, that the swelling on the sides of the neck continues to decrease and that the tumors are almost not palpable.

His quality of life continues to improve in January 2019, where he comments that he no longer has phlegm, the pain is intermittent and he is sleeping much better.

In March 2019, Raul tells us that the swelling in his neck continues to decrease, as does the pain and that he has generally been feeling better.

Between March 2019 and May 2020 all of Raul's reports indicate that he has regained his normal life, that his quality of life is excellent and he no longer feels swelling in his neck, pain or feels the tumors to the touch.

However, he has not been able to undergo new tests due to the cost of the same, and because the doctors in public health care did not give him more treatment options, he is not being followed up either.

Despite this situation, the costs to obtain LifEscozul treatment are covered by our program, which eliminates one of Raul's concerns.


Despite thyroid cancer being one of the cancers that best responds to conventional treatment, this was not the case for Raul.

Mr. Raul Manzano has been on the LifEscozul Protocol for 4 years, and has only received this treatment for his thyroid cancer.

His results have been very positive, with progressive improvement in his quality of life, elimination of pain, elimination of inflammation in the neck and reduction of tumors.

It has been 4 years of constant communication, dose increases and specialized medical follow-up. The results have been very positive.

We are the LifEscozul Group and the results define us.

Next case

Juan Sebastián Hernandez - Lymphomas- Resultados con LifEscozul™

Juan Sebastián Hernandez

Burkitt's Lymphoma belongs to the non-Hodgkin's Lymphoma types and starts when the body produces abnormal lymphocytes in excess (white blood cells).

When Sebastian's case comes to us the first thing that stands out is his age, since at only 12 years old in May 2019 he was diagnosed with stage 3 Burkitt's Lymphoma, which indicated that the cancer was large in size and spread to other parts of the body.

View more